Lexicon Pharmaceuticals LXRX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's total current liabilities?
- Lexicon Pharmaceuticals (LXRX) reported total current liabilities of $9.9M in Q1 2026.
- How has Lexicon Pharmaceuticals's total current liabilities changed year-over-year?
- Lexicon Pharmaceuticals's total current liabilities decreased by 91.1% year-over-year, from $110.69M to $9.9M.
- What is the long-term trend for Lexicon Pharmaceuticals's total current liabilities?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's total current liabilities has grown at a -14.9% compound annual growth rate (CAGR), from $46.81M to $20.87M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.